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HIGH IMPACT PRACTICES

Detecting and managing hypertension in the extended
postnatal period
Preventing postnatal pre-eclampsia and eclampsia
WHAT IS THE HIGH-IMPACT PRACTICE IN
MATERNAL HEALTH?
Measure every woman’s blood pressure after birth,
daily until discharge and on each contact in the
extended postnatal period. (The extended postnatal
period is defined as 12 months following a birth).

HYPERTENSIVE DISORDERS IN PREGNANCY

All women should stay at a health facility for at least 24
hours after birth. If their blood pressure (BP) was raised,
then women should stay until their BP and other vital signs
are normal and treated or referred [1].
If women experienced a hypertensive disorder during
pregnancy or early postnatal period – regular checkups
(BP measurement) are required. Specifically at a minimum:
on Day 1 and once between Day 3 and 5 when the risk of
adverse cardiovascular event is high [1, 2]; again, at the 6
week and 3-month postnatal check, and when infants are
brought for immunization, and at any other contact with
the health system. Appropriate treatment of hypertension
postnatally is essential to prevent long-term maternal
morbidity.

BACKGROUND
Postnatal hypertension is most often caused by high BP
from pre-eclampsia and gestational hypertension that
continues after delivery. Pre-eclampsia may develop for
the first time after childbirth within the first 3-5 days but
may occur up to 4 weeks postnatal. Evidence suggests
that about 25% of women with hypertensive disorders in
pregnancy (HDPs) experience a deterioration of end organ
function postnatally (period spanning 6–8 weeks after
delivery).[4] Close BP monitoring after childbirth is highly
recommended, as 20-44% of maternal deaths occur in
low resource settings after childbirth [1, 5-9]. In the early
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KEY POINTS
•

The extended postnatal period provides a “window
of opportunity” to monitor a woman’s BP and to
check for persistent hypertension. Often women are
asymptomatic – meaning they are not aware that
their BP is high.

•

If BP is measured routinely at any contact with health
system during the extended postnatal period –
hypertension is more likely to be detected and
managed appropriately.

•

Women with pre-eclampsia have a 3.7-fold increased
risk of future hypertension, 2.2-fold risk of ischemic
heart disease, and 1.8-fold risk of stroke [3]

•

Measure every woman’s BP after birth, daily until
discharge. At a minimum on Day 1 and between
Days 3-5 after birth if discharged early).

•

If women continue to have high BP postnatally, they
must receive hypertensive medicines with close
follow-up [1,2].

•

Women who were previously normotensive during
pregnancy, may develop hypertension or preeclampsia for the first time after delivery.

postnatal period, women with pre-existing pre-eclampsia
who are hospitalized should be considered at high risk for
complications for at least 3–5 days and should have their
BP and clinical condition monitored closely [1, 8].
Women with early onset pre-eclampsia (< 34 weeks) and
gestational hypertension are at higher risk of developing
persistent cardiovascular impairment 12 months after
delivery [4]. Pre-eclampsia occurring early in pregnancy or
presenting in its severe form or persistence of proteinuria

beyond three to six months postnatally suggests possible
chronic hypertension or renal disease. The risk of chronic
diseases such as hypertension, ischemic heart disease,
stroke, renal disease, and diabetes mellitus increases
in women with pre-eclampsia before 37 weeks or have
had placental abruption or stillbirth [3]. Higher BMI and
history of diabetes mellitus is associated with postnatal
hypertension. It is possible that postnatal hypertension
represents sub-clinical/asymptomatic or unresolved
hypertension [10].

Definitions: Hypertensive disorders of pregnancy
•

Women who have had gestational hypertension or preeclampsia should receive a comprehensive medical
review within six to eight weeks after delivery, and at
other contacts with the health system for up to 12
months, as well as discuss increased lifetime
cardiovascular risk, anti-hypertensive treatment, and
risk in future pregnancy [5,8].
Detecting, and/or managing unresolved BP during
postnatal period is one of several promising high impact
practices in maternal health. HIPs are identified by a
technical working group (TWG) of international experts.
This promising practice has limited evidence, with more
information needed to fully document implementation
experience and practice. The TWG advises that these
practices be promoted widely, provided that they are
implemented within the context of research and are
carefully evaluated in terms of both process and impact.
For more information about other HIPs, see https://www.
popcouncil.org/research/ending-eclampsia1.

WHY IS THIS PRACTICE IMPORTANT?
Hypertension is a leading cause of admission postnatally.
Early detection prevents complications. Between
30% and 40% of women who experience eclampsia
occurs in the postnatal period [11]. In addition to using
antihypertensives to control high BP, severe pre-eclampsia
and eclampsia (seizures) are managed using magnesium
sulphate (MgSO4) [1,2,8].
Hypertension that appears for the first time postnatally
does so most commonly on days 3–6. Hypertension
should be recognized and effectively treated to prevent
increases in severity and to avoid unnecessary delays in
discharge.
A third of women who have HDPs will have sustained
hypertension postnatally, although often their BP may
seem normal in the early postnatal period [12, 13].

2

Pre-eclampsia and Eclampsia
•

Pre-eclampsia: Onset of a new episode of
hypertension after 20 weeks of pregnancy
or postpartum, characterized by: persistent
hypertension (systolic BP ≥ 140 mm Hg diastolic
BP ≥ 90 mm Hg) and substantial proteinuria (> 0.3
g/24 hours) or any biochemical or hematological
abnormality.

•

Severe pre-eclampsia is pre-eclampsia with
severe signs and symptoms(severe headache,
upper abdominal pain, blurred vision, decreased
urine output)

•

Eclampsia: Generalized seizures, in addition to
pre-eclampsia criteria

•

Gestational hypertension: hypertension (≥140/≥90
mm Hg) after 20 weeks of pregnancy without
proteinuria or any biochemical or hematological
abnormality

•

Chronic hypertension: pre-existing high BP (≥140
mmHg systolic or ≥90 mmHg) before the onset of
pregnancy or diagnosed in the first 20 weeks of
gestation

•

Hypertension: BP of ≥ 140 mmHg systolic and/or ≥
90 mmHg diastolic

•

Severe hypertension: BP ≥ 160 mmHg systolic or
≥110 mmHg diastolic

Appropriate treatment of postnatal hypertension is
essential to prevent maternal morbidity and mortality
from cerebral hemorrhage [12, 13].
Hypertensive disorders of pregnancy and the
postnatal period are associated with several long-term
complications, including potential complications in future
pregnancies and a high lifetime risk of cardiovascular
disease (chronic hypertension, ischemic heart disease,
stroke, dementia) [1,3].

CHALLENGES OF ADHERING TO
RECOMMENDATIONS TO MONITOR BP
IN POSTNATAL PERIOD
The current World Health Organization (WHO) PNC
recommendations include close follow up on Day 1
and 3, within 1 to 2 weeks and again at 6 weeks [14].
However, the short time women stay post-delivery in
health facilities and the poor quality of postnatal contacts
in many countries reflect the lack of importance given to
comprehensive PNC [9].
In Nigeria, the national clinical guidelines recommend
daily BP measurement for the first 3 days after delivery
for women who suffered from HPD, and at least once
between days 3–5. In a cohort of 406 women who
had experienced HPD in eight tertiary health facilities
in Nigeria, 99% of women had a BP check on the day
after childbirth. However, adherence progressively
declined over the next four days, and by the fifth day
postnatal, BP was only checked in 38% of women [15].
In a similar study in Bangladesh, 89% of women with
HDPs had their BP measured on the first day after giving
birth, but again by the fifth day BP was only checked in
16% of women [16]. In Nigeria, the BP of women with
chronic hypertension remained high (71%) one year after
childbirth. However, 38%, 36%, and 16% of women with
gestational hypertension, pre-eclampsia, and eclampsia,
respectively, also remained hypertensive [15].

Women at risk of developing postnatal
hypertension (Smith et al 2013)
•
•
•
•

Preterm delivery triggered by
maternal hypertensive disease
Hypertension requiring
antenatal treatment
Severe antenatal hypertension
(>160/110mmHg)
Antenatal pre-eclampsia

>75%

33%

WHAT IS THE POTENTIAL IMPACT OF
IMPLEMENTING PROMISING BEST
PRACTICES?
•

Early detection and management of hypertension in
the postnatal period results in timely treatment and
follow up

•

Women are more aware of the long-term health
implications resulting in improved health literacy

•

Women with non-communicable disease may be better
prepared for a future pregnancy

•

Potentially expediated reduction in maternal morbidity
and mortality
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days, 2 weeks and 6 weeks after birth and any future
contact with the health system [1, 2]
•

PNC should be an ongoing process rather than a single
encounter, and all women should have contact with
health system within the first three weeks postnatal
and beyond [1, 14, 17]

•

Develop PNC protocols for all recommended contacts
and ensure protocols include monitoring of BP and
management of hypertension

•

If there is no Group ANC model in place, consider
extending to Group PNC – this provides peer support
to continue to monitor BP into the extended PNC
period. If no Group ANC consider initiating a “Mothers
and Baby’s club” at community level.

EXTENDED POSTNATAL PERIOD (6
WEEKS TO 12 MONTHS)

HOW TO DO IT: TIPS FROM
IMPLEMENTATION EXPERIENCE

•

After 6 weeks, use every contact that a woman has
with the health system to reduce missed opportunities
to check their BP. Such instances include when
bringing their baby for check-ups, growth monitoring,
immunizations and for postnatal family planning.

•

Integrate services with primary care to ensure
seamless transition for care throughout the life
course. At any facility contact beyond 6 months
monitor BP if previously high and referral to
physicians. It is important to consider continuous
family care or life cycle approach [18]

Based on programmatic experience, the following
strategies can help facilitate successful monitoring of
BP in the extended postnatal period to improve early
detection and management of hypertension.
•

Consider the context and level of health facility and
skills of different cadres. Recognize skills mix of
available health care providers. Community health
workers (CHWs) can provide information to women
and families on postnatal complications. Lower level
providers (including CHWs) are capable of measuring
BP, and primary health care (PHC) providers can
manage/refer women with hypertensive disorders
in the postnatal period (including administration of
MgSo4).

PATIENT LITERACY
•

Counsel women treated for HDPs about increased
risk of future heart disease. Advise women about
future pregnancy risks and health and the need for
routine BP checks.

•

Challenges in health-seeking behavior in the
postnatal period need to be addressed. Women with
pregnancy and postnatal complications and their
families require more information to enable them
to be aware of potential future health complications
and why they should attend follow-up consultations
and ask for BP checks.

•

Identify opportunities to discuss with communities
the risks in future pregnancies and long-term health
risks for women with HDPs, and find ways to bring
them for follow-up or how to increase efficiency of the
service providers for effective counseling.

POSTNATAL PERIOD (0-6 WEEKS)
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•

Women with HDPs should be automatically referred to
physician/specialist for follow-up

•

Review international guidelines on HDPs in PNC and
adapt country level guidelines and protocols for health
workers. Follow WHO recommendations for PNC
contacts: measure BP immediately after birth, 3-7

Recommendations on measuring BP and managing
hypertension postnatally.
•

Measure BP after birth, [1,2] and continued daily till
discharge [1].

•

Provide close postnatal follow up until BP continues
to be normal/returns to normal or is managed
appropriately.

•

Treat women with antihypertensive drugs in the
postnatal period if they: (1) have severe hypertension;
or (2) were treated with antihypertensive drugs
during pregnancy [2]. Keep BP at less than
160/110mmHg. Further investigation is required
if hypertension persists beyond three months [1].
(ISSHP 2018).

•

•

•

•

•

There is a lack of policy guidelines for task sharing
related to measuring and managing high BP,
conducting comprehensive care, and treating
hypertension, including administering loading dose
of MgSO4 and antihypertensives.

•

Women leave health facilities soon after birth and do
not complete recommended PNC contacts (including
BP measurement and management) due to lack of
awareness of risks.

PRIORITY RESEARCH AREAS
•

What is driving the increase in postnatal pre-eclampsia/
eclampsia?

•

Linking pre-eclampsia and gestational hypertension
to NCDs in lower middle income countries: long term
effect and survival re women getting the right care;
maternal mental health (postpartum depression,
anxiety, and PTSD) linked to HDPs.

•

Review all women at 3 months postnatal by which
time BP, urinalysis, and laboratory tests should
have normalized [1]. If these indicators haven’t
normalized, refer to physicians as appropriate.

How to best deliver postpartum cardiovascular risk
reduction programs in lower middle income countries

•

What is the ideal duration of MgSO4 as an
anticonvulsant postnatally?

Develop and strengthen postnatal policy/protocols
to ensure women who experienced pre-eclampsia/
eclampsia are followed up. This includes providing
a client held “HDP card” to record her BP and other
tests during the extended postnatal period.

•

Large longitudinal cohorts to embrace “Fourth
Trimester” using a life course perspective

•

Evaluate intervention and review plans for scale up
and scalability

Review women’s risk factors on discharge (and at
subsequent PNC contacts), and inform women with
HDPs of the risk of recurrence in future pregnancies
[8] and future cardiovascular risks [12].

FACTORS THAT INHIBIT SUCCESS
•

•

Policy factors: There are notable inconsistencies
on when to measure BP and how to manage
hypertension in both the immediate and extended
postnatal period at global and national levels [19].
Structural drivers: Poor procurement processes;
one BP cuff shared between ANC, labor and delivery
and other departments; and poor quality of BP
measurement tools, including a lack of validated
BP measurement machines, cuffs and stethoscope;
limited awareness of all cadres of health providers on
importance of routine BP measurement; limited skills
updates; staff shortages; and frequent turnover.
Poor coordination or lack of teamwork between
PHC level, midwives, obstetricians, and physicians,
resulting in women getting lost in the system.

INDICATORS FOCUSING ON PREECLAMPSIA AND BP: FROM WHO
STANDARDS OF MNH QOC
•

The proportion of all women in PNC wards or areas
in the health facility who have documented problems
of BP, pulse rate, vaginal bleeding, lochia or
breastfeeding. (84.02)

•

The health facility has functioning essential
equipment and supplies for the detection of
complications (e.g. thermometers, sphygmomanometers, fetal stethoscopes, urine dipsticks, pulse
oximeter) in sufficient quantities at all times in the
labour and childbirth areas of the maternity unit.
(91.63)

•

The health facility has written, up-to-date clinical
protocols on the management of pre-eclampsia that
are available in the labour, childbirth and postnatal
areas and are consistent with WHO guidelines.
(90.59)
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•

•

•

Health-care staff in the maternity unit receive inservice training and regular refresher sessions in the
use of antihypertensive agents, intravenous infusion
and MgSO4 for treating pre-eclampsia and eclampsia
at least once every 12 months. (84.54)
The proportion of all women discharged postpartum
within the past 24 hours had an accurately
completed record of processes of care, treatments,
outcomes and diagnoses (with ICD code). (82.88)
The health facility has supplies of antihypertensive
agents and MgSO4 (and the antidote calcium
gluconate) in sufficient quantities, available at all
times, in antenatal, labour, childbirth and postnatal
areas for the management of women with preeclampsia. (92.81)

TOOLS AND RESOURCES
•

FIGO https://www.figo.org/preeclampsia-guidelines

•

ISSHP Classification, Diagnosis, and Management
Recommendations for International Practice

•

Nathan HL, Duhig K, Hezelgrave NL, Chappell LC,
Shennan AH. Blood pressure measurement in
pregnancy. The Obstetrician & Gynaecologist 2015;
17:91–8.

•

NICE Hypertension in pregnancy: diagnosis and
management guideline [NG133] NHS UK 2019

•

World Health Organization. WHO recommendations
for the prevention and treatment of pre-eclampsia/
eclampsia. Geneva; 2011 http://apps.who.int/iris/
bitstream/10665/44703/1/9789241548335_eng.
pdf

•
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World Health Organization. WHO recommendations
on postnatal care of the mother and newborn.
Geneva,
2013
http://www.who.int/maternal_
child_adolescent/documents/postnatal-carerecommendations/en/.

•

WHO 2016 Standards for improving quality of
maternal and newborn care in health facilities WHO
2017 Managing Complications in Pregnancy and
Childbirth (MCPC): A Guide for Midwives and Doctors
second edition.

•

WHO Integrating Management of Pregnancy and
Childbirth (IMPAC): 2017 Consider highlighting
aspects of IMPAC related to integration with
immunization/child health services related to
reducing missed opportunities for women’s checkups
in the postnatal period.

REFERENCES
1.

Brown M, Laura A. Magee, Louise C. Kenny, et al, on
behalf of the International Society for the Study of
Hypertension in Pregnancy (ISSHP) Hypertensive
Disorders of Pregnancy: ISSHP Classification, Diagnosis,
and Management Recommendations for International
Practice Hypertension. 2018; 72:24-43

2.

World Health Organization (WHO) Recommendations
for prevention and treatment of pre-eclampsia and
eclampsia, World Health Organization 2011. Available
at
Website:
https://apps.who.int/iris/bitstream/
handle/10665/44703/9789241548335_eng.pdf
Accessed 29 Dec. 2019

3.

Bramham Kate, Nelson- Piercy Catherine, Brown
Morris J, Chappell Lucy C. Postpartum management of
hypertension BMJ 2013

4.

Deruelle P, Coudoux E, Ego A, Houfflin-Debarge V,
Codaccioni X, Subtil D. Risk factors for post-partum
complications occurring after preeclampsia and HELLP
syndrome. A study in 453 consecutive pregnancies. Eur
J Obstet Gynecol Reprod Biol 2006; 125(1):59–65

5.

Royal College of Obstetricians & Gynaecologists. Greentop Guideline 37a: Reducing the risk of thrombosis and
embolism during pregnancy and the puerperium. 2015;
Available at: https://www.rcog.org.uk/en/guidelinesresearch-services/guidelines. Accessed Jul/19, 2015.

6.

Firoz T, Melnik T. Postpartum evaluation and longterm implications. Best Pract Res Clin Obstet
Gynaecol. 2011;25(4):549–561. doi: 10.1016/j.
bpobgyn.2011.03.003

7.

Firoz T, Sotunsa J. Adetoro OO. Treatment postpartum
– immediate and long term. In: The Federation of
Gynecology and Obstetrics (FIGO) Textbook of Pregnancy
Hypertension. Eds. Magee LA & von Dadelszen P. The
Global Library of Women’s Medicine, London, 2016,
pp 215-232.https://www.glowm.com/resource_type/
resource/textbook/title/the-figo-textbook-of-pregnancyhypertension/resource_doc/2768

8.

NICE Hypertension in pregnancy: diagnosis and
management guideline [NG133] NHS UK 2019

9.

Benova L, Owolabi O, Radovich E, Wong KLM, Macleod
D, Langlois EV, et al. (2019) Provision of postpartum care
to women giving birth in health facilities in sub-Saharan
Africa: A cross-sectional study using Demographic
and Health Survey data from 33 countries. PLoS Med
16(10): e1002943. https://doi.org/10.1371/journal.
pmed.1002943

10. Goel A, Rana S. Angiogenic factors in preeclampsia:
potential for diagnosis and treatment. Curr Opin
Nephrol Hypertens. 2013;22(6):643–650 doi:10.1097/
MNH.0b013e328365ad98
11. Magee LA, Sharma S, Nathan HL, Adetoro OO, Bellad
MB, Goudar S, Macuacua SE, Mallapur A, Qureshi
R, Sevene E, Sotunsa J. The incidence of pregnancy
hypertension in India, Pakistan, Mozambique, and
Nigeria: A prospective population-level analysis. PLoS
medicine. 2019 Apr 12;16(4): e1002783.
12. Smith, Marie., Jason Waugh, Catherine Nelson Piercy
Management of postpartum hypertension 2013. The
Obstetrician & Gynaecologist. http://onlinetog.org
https://doi.org/10.1111/j.1744-4667.2012.00144
13. Melchiorre K, Sutherland GR, Liberati M, Thilaganathan
B. Preeclampsia is associated with persistent
postpartum cardiovascular impairment. Hypertension
2011 Oct;58(4):709–715.
14. World Health Organization. WHO recommendations on
postnatal care of the mother and newborn. Geneva,
2013 http://www.who.int/maternal_child_adolescent/
documents/postnatal-care-recommendations/en/.
15. Warren CE, Ishaku SM et al, Landscape Analysis of Preeclampsia/Eclampsia in Nigeria Report. New York, USA:
Population Council; 2016

16. Hossain S, Roy S, Sultana K, Warren CE. Assessing
the effect of a primary health care intervention for
improving pre-eclampsia and eclampsia knowledge
and practice in Bangladesh. New York USA: Population
Council; 2019.
17. ACOG Practice Bulletin No. 202/203. Gestational
hypertension and preeclampsia. American College
of Obstetricians and Gynecologists. Obstet Gynecol
2019;133: e1–25.
18. Arabin, Birgit and Ahmet A. Baschat. Pregnancy:
An Underutilized Window of Opportunity to Improve
Long-term Maternal and Infant Health—An Appeal
for Continuous Family Care and Interdisciplinary
Communication Front. Pediatr. 5:69. doi: 10.3389/
fped.2017.00069
19. Gillon TE, Pels A, von Dadelszen P, MacDonell K, Magee
LA. Hypertensive disorders of pregnancy: a systematic
review of international clinical practice guidelines. PLoS
One. 2014;9(12):e113715. Published 2014 Dec 1.
doi:10.1371/journal.pone.0113715

Acknowledgments: This document was originally
drafted by Charlotte Warren. Critical review and
helpful comments were provided by Deborah
Armbruster, Tabassum Firoz, Emily Hillman, Sharif
Hossain, Salisu Ishaku, Karen Kirk, Tracy McClair,
Pooja Sripad, and Catherine Taylor.
For further information please contact us at
MNH-PCDC@popcouncil.org

Suggested citation: High-Impact Practices (HIPs) in Maternal and Newborn Health. Detecting and managing hypertension
in the extended postnatal period: Supporting women to be at the center of their own care as active participants. Washington
(DC): Population Council; 2020. Available from: https://www.popcouncil.org/research/ending-eclampsia1

7

